Cocrystal Pharma to Present at the 12th Annual LD Micro Main Event
December 04 2019 - 8:00AM
Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or
the “Company”), a clinical stage biotechnology company
discovering and developing novel antiviral therapeutics,
announced today that Dr. Gary Wilcox, Chairman and Chief Executive
Officer of Cocrystal, will present a corporate overview at the 12th
Annual LD Micro Main Event on Tuesday, December 10, 2019 at 4:40 pm
PST in Bel-Air, CA.
In addition to the presentation, management will
also be available to participate in one-on-one meetings with
qualified members of the investor community who are registered to
attend the conference.
About Cocrystal Pharma,
Inc.
Cocrystal Pharma, Inc. is a clinical stage
biotechnology company discovering and developing novel antiviral
therapeutics that target the replication machinery of influenza
viruses, hepatitis C viruses, and noroviruses. Cocrystal employs
unique structure-based technologies and Nobel Prize winning
expertise to create first- and best-in-class antiviral drugs. For
further information about Cocrystal, please visit
www.cocrystalpharma.com.
Investor and Media
Contact:Jenene Thomas Communications, LLC(833)
475-8247COCP@jtcir.com
###
Cocrystal Pharma (NASDAQ:COCP)
Historical Stock Chart
From Aug 2024 to Sep 2024
Cocrystal Pharma (NASDAQ:COCP)
Historical Stock Chart
From Sep 2023 to Sep 2024